Is ESI or CBT a better buy right now?

Based on our latest analysis, CBT is currently the stronger investment candidate based on our comprehensive scoring model.

Does ESI or CBT have better growth?

Our analysis compares revenue and earnings growth. Check the 'Growth' section above to see which company is expanding faster. Typically, the stock with higher revenue growth rates is considered the better growth stock.

Which stock is cheaper: ESI or CBT?

We compare P/E ratios and other valuation metrics in the 'Valuation' section. The stock with the lower P/E ratio is generally considered 'cheaper' relative to its earnings, though growth prospects must also be considered.

Which is the better buy right now, ESI or CBT?

As of Oct 22, 2026, CBT scores higher in our model: ESI has an AI score of 50.5 versus 55.6 for CBT. ESI is currently in a Markdown technical phase and CBT is in a Markdown phase. Consider both scores and phases alongside your own risk tolerance.

What technical phase are ESI and CBT in?

ESI is in a Markdown phase (Sell / avoid) with an RSI of 37.4. CBT is in a Markdown phase (Sell / avoid) with an RSI of 37.7.

ESI vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ESI

50.5

AI Score

CBT Wins

CBT

55.6

AI Score

Investment Advisor Scores

ESI

51score

Recommendation

HOLD

View Full Analysis

CBT

56score

Recommendation

HOLD

View Full Analysis

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric	ESI	CBT	Winner
Revenue	2.81B	2.73B	ESI
Net Income	198.90M	147.00M	ESI
Gross Margin	35.5%	22.1%	ESI
Net Margin	7.1%	5.4%	ESI
Operating Income	339.00M	356.00M	CBT
ROE	6.9%	9.2%	CBT
ROA	3.4%	3.7%	CBT
Total Assets	5.86B	3.98B	ESI
Cash	224.90M	250.00M	CBT
Current Ratio	2.78	1.47	ESI
Free Cash Flow	108.80M	126.00M	CBT

Relative Price Performance (Last 90 Days)

ESI 1M: -6.7% · 3M: -11.6% CBT 1M: -5.7% · 3M: -17.5%

Current Technical Phase

ESI

Markdown

Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 37

RSI (14): 37.4 · Price: $33.11

CBT

Markdown

Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $74.33

Fundamentals Snapshot

Metric	ESI	CBT
Market Cap	—	—
Forward P/E	15.5	10.6
Trailing P/E	49.1	20.7
Revenue (TTM)	—	—
Revenue Growth	0.6%	0.1%
Gross Margin	0.4%	0.2%
Operating Margin	0.1%	0.1%
EPS	0.74	3.57
Dividend Yield	0.01%	0.02%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.

Related Analysis

ESI

CBT

Data derived from SEC EDGAR filings and Tradestie proprietary analysis. Last updated: Oct 22, 2026 20:04 UTC. Refresh Data

Tradestie